Promising outlook with sugemalimab in non-small-cell lung cancer. Rosell R, Cao P. Lancet Oncol 2022 Jan 14. pii: S1470-2045(21)00698.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rosell R, Cao P. Promising outlook with sugemalimab in non-small-cell lung cancer. Lancet Oncol 2022 Jan 14. pii: S1470-2045(21)00698.
PMID: 35038431